Autoimmune lymphoproliferative syndrome is a rare disorder characterized by mutations in either Fas or FasL (Rieux-Laucat et al., 1995; Del-Rey et al., 2006), which results in defective Fas-mediated apoptosis and, consequently, the abnormal accumulation of activated lymphocytes. Here, FAS is linked to autoimmune lymphoproliferative syndrome.